Christina Rau

6.6k total citations
10 papers, 350 citations indexed

About

Christina Rau is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Christina Rau has authored 10 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Hematology. Recurrent topics in Christina Rau's work include Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Click Chemistry and Applications (2 papers). Christina Rau is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Click Chemistry and Applications (2 papers). Christina Rau collaborates with scholars based in Germany, United States and United Kingdom. Christina Rau's co-authors include Marcus Bantscheff, Douglas W. Thomson, Marcel Muelbaier, Rab K. Prinjha, Darren J. Mitchell, Thilo Werner, Paul Bamborough, Paola Grandi, Chun‐wa Chung and Robert J. Watson and has published in prestigious journals such as Angewandte Chemie International Edition, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Christina Rau

10 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christina Rau Germany 9 283 74 66 63 38 10 350
Teodora Pene Dumitrescu United States 11 318 1.1× 26 0.4× 35 0.5× 46 0.7× 88 2.3× 20 522
Songping Zhao Canada 9 251 0.9× 34 0.5× 74 1.1× 55 0.9× 77 2.0× 13 473
Charles McNemar United States 7 216 0.8× 19 0.3× 35 0.5× 108 1.7× 43 1.1× 8 401
Nicholas A. Eleuteri United States 9 630 2.2× 136 1.8× 30 0.5× 250 4.0× 24 0.6× 9 691
Elizabeth C. Townsend United States 8 311 1.1× 32 0.4× 23 0.3× 48 0.8× 27 0.7× 24 443
Pablo Ríos‐Marco Spain 14 289 1.0× 11 0.1× 28 0.4× 59 0.9× 55 1.4× 25 463
Jingjin Gao United States 8 123 0.4× 35 0.5× 34 0.5× 69 1.1× 111 2.9× 11 337
Shihan He United States 8 569 2.0× 230 3.1× 43 0.7× 84 1.3× 19 0.5× 15 702
Chunlan Pu China 14 285 1.0× 54 0.7× 15 0.2× 136 2.2× 11 0.3× 32 434
Deepak Bararia Germany 11 206 0.7× 146 2.0× 84 1.3× 78 1.2× 12 0.3× 17 446

Countries citing papers authored by Christina Rau

Since Specialization
Citations

This map shows the geographic impact of Christina Rau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Rau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Rau more than expected).

Fields of papers citing papers by Christina Rau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Rau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Rau. The network helps show where Christina Rau may publish in the future.

Co-authorship network of co-authors of Christina Rau

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Rau. A scholar is included among the top collaborators of Christina Rau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Rau. Christina Rau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Eberl, H. Christian, Thilo Werner, Friedrich Reinhard, et al.. (2019). Chemical proteomics reveals target selectivity of clinical Jak inhibitors in human primary cells. Scientific Reports. 9(1). 14159–14159. 33 indexed citations
2.
Thomson, Douglas W., Daniel Poeckel, Nico Zinn, et al.. (2019). Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor. ACS Medicinal Chemistry Letters. 10(5). 780–785. 66 indexed citations
3.
Bamborough, Paul, Chun‐wa Chung, Rebecca C. Furze, et al.. (2018). Aiming to Miss a Moving Target: Bromo and Extra Terminal Domain (BET) Selectivity in Constrained ATAD2 Inhibitors. Journal of Medicinal Chemistry. 61(18). 8321–8336. 18 indexed citations
4.
Thomson, Douglas W., Marcus Bantscheff, R. Edward Benson, et al.. (2017). Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell Lines. Journal of Medicinal Chemistry. 60(13). 5455–5471. 24 indexed citations
5.
Bamborough, Paul, Chun‐wa Chung, Emmanuel H. Demont, et al.. (2016). A Chemical Probe for the ATAD2 Bromodomain. Angewandte Chemie. 128(38). 11554–11558. 10 indexed citations
6.
Bamborough, Paul, Chun‐wa Chung, Emmanuel H. Demont, et al.. (2016). A Chemical Probe for the ATAD2 Bromodomain. Angewandte Chemie International Edition. 55(38). 11382–11386. 51 indexed citations
7.
Nixon, Elizabeth, et al.. (2015). Screening Pools of Compounds against Multiple Endogenously Expressed Targets in a Chemoproteomics Binding Assay. SLAS TECHNOLOGY. 21(1). 133–142. 8 indexed citations
8.
Bamborough, Paul, Chun‐wa Chung, Rebecca C. Furze, et al.. (2015). Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors. Journal of Medicinal Chemistry. 58(15). 6151–6178. 64 indexed citations
9.
Gaither, L. Alex, Jason Borawski, Leah J. Anderson, et al.. (2009). Multiple cyclophilins involved in different cellular pathways mediate HCV replication. Virology. 397(1). 43–55. 75 indexed citations
10.
Rau, Christina, et al.. (1978). The contribution of cytochemistry and electron microscopy to the detection of contaminants in the cell material used for the production of virus vaccines.. PubMed. 37. 245–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026